Preferred Name |
minaxolone |
|
Synonyms |
Pregnan-20-one, 11-(dimethylamino)-2-ethoxy-3-hydroxy-, (2beta,3alpha,5alpha,11alpha)- |
|
ID |
http://purl.bioontology.org/ontology/MESH/C020413 |
|
altLabel |
Pregnan-20-one, 11-(dimethylamino)-2-ethoxy-3-hydroxy-, (2beta,3alpha,5alpha,11alpha)- 11 alpha-N,N-dimethylamino-2 beta-ethoxy-3 alpha-hydroxy-5 alpha-pregnan-20-one 2 beta-ethoxy-3 alpha-hydroxy-11 alpha-dimethylamino-5 alpha-pregnan-20-one minaxolone citrate, (2beta,3alpha,5alpha,11alpha)-isomer |
|
cui |
C0090916 C0066562 C0890375 |
|
Has mapping qualifier | ||
HM |
D011280/Q000031 |
|
Inverse of RB |
737SKC73L0 65079-75-6 |
|
isa | ||
Mapped to | ||
MDA |
19790101 |
|
MeSH Frequency |
41 |
|
MMR |
20190701 |
|
notation |
C020413 |
|
PA |
D000081227 D000777 |
|
prefLabel |
minaxolone |
|
RR |
62571-87-3 (minaxolone) 65079-75-6 (citrate(2beta,3alpha,5alpha,11alpha)-isomer) |
|
SC |
1 |
|
Scope Statement |
RN given refers to parent cpd(2beta,3alpha,5alpha,11alpha)-isomer |
|
SRC |
Lancet 2(8133):71;1979 Br J Anaesth 1980;52(2):241 Canad Anaesth Soc J 1980;27(2):140 Lancet 2(8133):73;1979 |
|
TERMUI |
T104102 T104101 T000962378 T344196 T104103 |
|
TH |
NLM (1979) NLM (2020) FDA SRS (2013) USAN (19XX) INN (19XX) |
|
tui |
T109 T121 |